10 things you need to know today: December 11, 2020

An FDA panel recommends approving emergency use of Pfizer vaccine, swing states criticize "seditious" Texas election lawsuit, and more

The Pfizer vaccine
(Image credit: Getty Images)

1. FDA panel recommends approving Pfizer vaccine for emergency use

A Food and Drug Administration advisory committee on Thursday recommended authorizing emergency use of Pfizer's coronavirus vaccine, saying the potential benefits outweigh the risks. The decision by the independent panel cleared the way for the expected approval of the two-shot vaccine for people 16 and older. The vaccine developed by Pfizer and its German partner BioNTech is the first to go through the FDA review. The FDA first doublechecked Pfizer's trial data and determined that it met U.S. standards for emergency use. The federal government is gearing up for a massive vaccination campaign to begin next week, starting with priority groups, including health-care workers and residents of long-term care facilities.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
Explore More
Harold Maass, The Week US

Harold Maass is a contributing editor at The Week. He has been writing for The Week since the 2001 debut of the U.S. print edition and served as editor of TheWeek.com when it launched in 2008. Harold started his career as a newspaper reporter in South Florida and Haiti. He has previously worked for a variety of news outlets, including The Miami Herald, ABC News and Fox News, and for several years wrote a daily roundup of financial news for The Week and Yahoo Finance.